BE798051A - Derives de la dopamine - Google Patents

Derives de la dopamine

Info

Publication number
BE798051A
BE798051A BE1004956A BE1004956A BE798051A BE 798051 A BE798051 A BE 798051A BE 1004956 A BE1004956 A BE 1004956A BE 1004956 A BE1004956 A BE 1004956A BE 798051 A BE798051 A BE 798051A
Authority
BE
Belgium
Prior art keywords
dopamine derivatives
dopamine
derivatives
Prior art date
Application number
BE1004956A
Other languages
English (en)
French (fr)
Inventor
R R Tutile
J Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE798051(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE798051A publication Critical patent/BE798051A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE1004956A 1972-04-12 1973-04-11 Derives de la dopamine BE798051A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
BE798051A true BE798051A (fr) 1973-10-11

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1004956A BE798051A (fr) 1972-04-12 1973-04-11 Derives de la dopamine

Country Status (31)

Country Link
JP (2) JPS5825656B2 (US07223432-20070529-C00017.png)
KR (1) KR790000113B1 (US07223432-20070529-C00017.png)
AR (1) AR203822A1 (US07223432-20070529-C00017.png)
AT (1) AT323719B (US07223432-20070529-C00017.png)
AU (1) AU472734B2 (US07223432-20070529-C00017.png)
BE (1) BE798051A (US07223432-20070529-C00017.png)
BG (1) BG23001A3 (US07223432-20070529-C00017.png)
CA (1) CA1018188A (US07223432-20070529-C00017.png)
CH (2) CH580563A5 (US07223432-20070529-C00017.png)
CS (2) CS190406B2 (US07223432-20070529-C00017.png)
CY (1) CY963A (US07223432-20070529-C00017.png)
DD (1) DD107670B3 (US07223432-20070529-C00017.png)
DE (1) DE2317710C2 (US07223432-20070529-C00017.png)
DK (1) DK142750C (US07223432-20070529-C00017.png)
ES (1) ES413639A1 (US07223432-20070529-C00017.png)
FR (1) FR2182947B1 (US07223432-20070529-C00017.png)
GB (1) GB1392674A (US07223432-20070529-C00017.png)
HK (1) HK50178A (US07223432-20070529-C00017.png)
HU (2) HU167597B (US07223432-20070529-C00017.png)
IE (1) IE37511B1 (US07223432-20070529-C00017.png)
IL (1) IL42016A (US07223432-20070529-C00017.png)
KE (1) KE2870A (US07223432-20070529-C00017.png)
MY (1) MY7800381A (US07223432-20070529-C00017.png)
NL (1) NL174459C (US07223432-20070529-C00017.png)
PH (1) PH11041A (US07223432-20070529-C00017.png)
PL (2) PL90695B1 (US07223432-20070529-C00017.png)
RO (2) RO65105A (US07223432-20070529-C00017.png)
SE (1) SE399064B (US07223432-20070529-C00017.png)
SU (1) SU496719A3 (US07223432-20070529-C00017.png)
YU (2) YU36483B (US07223432-20070529-C00017.png)
ZA (1) ZA732136B (US07223432-20070529-C00017.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (US07223432-20070529-C00017.png) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
EP0071399A3 (en) * 1981-07-22 1983-12-07 Syntex (U.S.A.) Inc. Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (US07223432-20070529-C00017.png) * 1989-12-18 1991-08-23
CA2103367A1 (en) * 1991-05-20 1992-11-21 Akihide Koda Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
EP1546088B1 (en) 2002-10-03 2014-12-17 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (ja) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
SG178191A1 (en) 2009-07-31 2012-03-29 Cognition Therapeutics Inc Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CA2846604A1 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2915833T3 (es) 2014-01-31 2022-06-27 Cognition Therapeutics Inc Composiciones de isoindolina y métodos para tratar una enfermedad neurodegenerativa y una degeneración macular
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU37113B (en) 1984-08-31
PL94207B1 (US07223432-20070529-C00017.png) 1977-07-30
NL174459B (nl) 1984-01-16
DE2317710C2 (de) 1983-08-04
DE2317710A1 (de) 1973-10-18
DD107670B3 (de) 1988-04-06
AU5438573A (en) 1974-10-17
YU321279A (en) 1983-04-27
FR2182947A1 (US07223432-20070529-C00017.png) 1973-12-14
JPS5825656B2 (ja) 1983-05-28
SU496719A3 (ru) 1975-12-25
RO65105A (ro) 1980-01-15
HU167597B (US07223432-20070529-C00017.png) 1975-11-28
CA1018188A (en) 1977-09-27
AR203822A1 (es) 1975-10-31
PH11041A (en) 1977-10-25
HU166213B (US07223432-20070529-C00017.png) 1975-02-28
NL174459C (nl) 1984-06-18
CH569691A5 (US07223432-20070529-C00017.png) 1975-11-28
HK50178A (en) 1978-09-15
RO70892A (ro) 1982-02-26
ZA732136B (en) 1974-03-27
KE2870A (en) 1978-09-01
YU97673A (en) 1982-02-25
PL90695B1 (US07223432-20070529-C00017.png) 1977-01-31
CY963A (en) 1978-12-22
KR790000113B1 (en) 1979-03-20
IL42016A0 (en) 1973-06-29
JPS497237A (US07223432-20070529-C00017.png) 1974-01-22
MY7800381A (en) 1978-12-31
AT323719B (de) 1975-07-25
AU472734B2 (en) 1976-06-03
DD107670A5 (de) 1974-08-12
IE37511B1 (en) 1977-08-03
YU36483B (en) 1984-02-29
DK142750B (da) 1981-01-12
IL42016A (en) 1976-05-31
NL7305097A (US07223432-20070529-C00017.png) 1973-10-16
ES413639A1 (es) 1976-01-16
CS190448B2 (en) 1979-05-31
JPS6221343B2 (US07223432-20070529-C00017.png) 1987-05-12
SE399064B (sv) 1978-01-30
CS190406B2 (en) 1979-05-31
BG23001A3 (US07223432-20070529-C00017.png) 1977-05-20
JPS58131945A (ja) 1983-08-06
GB1392674A (en) 1975-04-30
DK142750C (da) 1981-08-17
FR2182947B1 (US07223432-20070529-C00017.png) 1976-07-02
CH580563A5 (US07223432-20070529-C00017.png) 1976-10-15

Similar Documents

Publication Publication Date Title
BE804913A (fr) Derives tetracycliniques
BE763298A (fr) Derives de benzylimidazolidinone
BE810511A (fr) Derives de la benzotriazine-1
AR200751A1 (es) Derivados de cromano
BE801597A (fr) Derives enoliques
BE798051A (fr) Derives de la dopamine
SE417968B (sv) Forfarande for framstellning av penamderivat
BE808035A (fr) Derives de gamma-glutamyl-p-nitranilide
BE776514A (fr) Derives de triazolobenzodiazepine
AR214383A1 (es) Derivados de dialquilfosfanatos
BE801965A (fr) Nouveaux derives de beta-phenoxyethanols
BE771513A (fr) Derives de thiopyrimidine
BE800207A (fr) Nouveaux derives de la phenylethylamine
BE750619A (fr) Derives de la phloramine
BE762595A (fr) Derives de benzocycloheptane-isoquinoleine
AR201288A1 (es) Derivados de alfa-cianmetansulfonamidobenceno
BE819515A (fr) Derives de la 4-amino-amphetamine
BE796507A (fr) Derives de morphinane
BE796540A (fr) Derives cephalosporins
BE795988A (fr) Derives de pyrazole
BE806433A (fr) Derives de cyclopentane
BE806808A (fr) Derives de bicycloalkyle
BE803388A (fr) Derives de borbornane
BE803483A (fr) Derives de pyrrolidine
IT1048503B (it) Derivati nitrobenzenici

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 19930411